Biocardia CEO Peter Altman acquires $1,488 in common stock
In a recent transaction, Peter Altman, President and CEO of BioCardia, Inc. (NASDAQ:BCDA), purchased 600 shares of the company's common stock. The shares were acquired at an average price of $2.48 per ...
Biocardia CEO Peter Altman acquires $1,488 in stock
BioCardia, Inc. (NASDAQ:BCDA), a micro-cap biotech company with a market value of $11.4 million, saw its President and CEO ...
US FDA approves SpringWorks' genetic disorder drug
The U.S. Food and Drug Administration said on Tuesday it has approved SpringWorks Therapeutics' drug to treat a type of rare ...
Digi Times2d
Japan approves Rapidus investment plan with tax incentives, new semiconductor bonds
Japan's Cabinet approved amendments to the Act on the Promotion of Information Processing and the Act on Special Accounts on ...
Japan PM Ishiba's approval rate rises 5 points to 44%, NHK poll shows
Japanese Prime Minister Shigeru Ishiba's cabinet approval rate rose 5 points from the previous month to 44% in a February 7-9 ...